Paper9702435
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.
Hollander PA and 14 others. Diabetes Care, 1998. Cited by 459 papers, by iCite.
Cite this record
ConductScience Library. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Papers, record 9702435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9702435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Body Weight | Major topic |
| Diabetes Mellitus | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diet, Reducing | Major topic |
| Enzyme Inhibitors | Major topic |
| Lactones | Major topic |
| Obesity | Major topic |
| Adult | |
| Apolipoproteins | |
| Blood Glucose | |
| Cholesterol | |
| Double-Blind Method | |
| Female | |
| Glycated Hemoglobin | |
| Humans | |
| Lipase | |
| Lipoproteins | |
| Male | |
| Middle Aged | |
| Orlistat | |
| Placebos | |
| Triglycerides |
Source PubMed
Cited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 459 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889937 | Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity. | Diabetes Obes Cardiometab CARE | 2026 | https://conductscience.org/library/papers/42889937 | PubMed |
| 42888986 | Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. | Diabetes Obes Cardiometab CARE | 2026 | https://conductscience.org/library/papers/42888986 | PubMed |
| 42812879 | Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42812879 | PubMed |
| 42242835 | Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. | BMJ Open Diabetes Res Care | 2026 | https://conductscience.org/library/papers/42242835 | PubMed |
| 41575672 | Anti-obesity Pharmacotherapy for Transplant Recipients. | Curr Atheroscler Rep | 2026 | https://conductscience.org/library/papers/41575672 | PubMed |
| 41529914 | Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity. | BMJ Open Diabetes Res Care | 2026 | https://conductscience.org/library/papers/41529914 | PubMed |
| 41358882 | 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026. | Diabetes Care | 2026 | https://conductscience.org/library/papers/41358882 | PubMed |
| 41111360 | Efficacy and safety of European Medicines Agency (EMA)-approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta-analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/41111360 | PubMed |
| 40730197 | Extinguishing the Fire: Treating Pediatric Type 2 Diabetes by Targeting Obesity Treatment. | Diabetes Care | 2025 | https://conductscience.org/library/papers/40730197 | PubMed |
| 40473479 | Efficacy of orlistat in type 2 diabetes: a systematic review and meta-analysis. | BJGP Open | 2025 | https://conductscience.org/library/papers/40473479 | PubMed |
| 40362407 | Combination of Berberine and Evodiamine Alleviates Obesity by Promoting Browning in 3T3-L1 Cells and High-Fat Diet-Induced Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362407 | PubMed |
| 39651976 | 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025. | Diabetes Care | 2025 | https://conductscience.org/library/papers/39651976 | PubMed |
| 39649696 | First-Generation Anti-Obesity Medications. | Diabetes Spectr | 2024 | https://conductscience.org/library/papers/39649696 | PubMed |
| 39175812 | Orlistat and metformin combination ameliorates obesity-induced renal injury via suppressing renal oxidative stress in male rats. | Toxicol Res (Camb) | 2024 | https://conductscience.org/library/papers/39175812 | PubMed |
| 39049073 | Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/39049073 | PubMed |
| 38910819 | Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | Proc (Bayl Univ Med Cent) | 2024 | https://conductscience.org/library/papers/38910819 | PubMed |
| 38466272 | Approach to Obesity Treatment in Primary Care: A Review. | JAMA Intern Med | 2024 | https://conductscience.org/library/papers/38466272 | PubMed |
| 38078578 | 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. | Diabetes Care | 2024 | https://conductscience.org/library/papers/38078578 | PubMed |
| 37049479 | Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland. | Nutrients | 2023 | https://conductscience.org/library/papers/37049479 | PubMed |
| 36992862 | Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/36992862 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
| PNLIP | 5406 | PubTator's text mining | https://conductscience.org/library/genes/5406 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9702435
GET https://conductscience.org/api/papers/v1/9702435/cited_by?page=2